Recently it has been shown that combined tet methylcytosine dioxygenase 2(TET2) and fms related tyrosine kinase 3 (FLT3) mutationsregulate epigenetic silencing of GATA2 by promotor hypermethylation inhuman AML (Ref. This evidence concerns the gene FLT3 and acute myeloid leukemia.